News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,852 Results
Type
Article (41613)
Company Profile (299)
Press Release (683929)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (205633)
Career Advice (2046)
Deals (35654)
Drug Delivery (110)
Drug Development (81607)
Employer Resources (174)
FDA (16502)
Job Trends (15017)
News (347817)
Policy (32831)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2605)
Accelerated approval (31)
Adcomms (25)
Allergies (137)
Alliances (49984)
ALS (168)
Alzheimer's disease (1668)
Antibody-drug conjugate (ADC) (309)
Approvals (16770)
Artificial intelligence (519)
Autoimmune disease (145)
Automation (38)
Bankruptcy (361)
Best Places to Work (11702)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (201)
Bladder cancer (159)
Brain cancer (56)
Breast cancer (643)
Cancer (4812)
Cardiovascular disease (402)
Career advice (1727)
Career pathing (36)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (736)
Cervical cancer (36)
Clinical research (69654)
Collaboration (1711)
Company closure (4)
Compensation (1139)
Complete response letters (52)
COVID-19 (2721)
CRISPR (91)
C-suite (824)
Cystic fibrosis (143)
Data (6180)
Decentralized trials (2)
Denatured (26)
Depression (134)
Diabetes (496)
Diagnostics (6788)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (245)
Drug pricing (184)
Drug shortages (29)
Duchenne muscular dystrophy (226)
Earnings (90250)
Editorial (55)
Employer branding (21)
Employer resources (153)
Events (118086)
Executive appointments (975)
FDA (19611)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1463)
Gene editing (199)
Generative AI (44)
Gene therapy (590)
GLP-1 (971)
Government (4669)
Grass and pollen (6)
Guidances (384)
Healthcare (19043)
HIV (56)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (249)
Immuno-oncology (55)
Indications (103)
Infectious disease (2980)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (246)
Interviews (319)
IPO (16685)
IRA (49)
Job creations (3655)
Job search strategy (1444)
JPM (57)
Kidney cancer (15)
Labor market (83)
Layoffs (547)
Leadership (31)
Legal (7956)
Liver cancer (92)
Longevity (14)
Lung cancer (643)
Lymphoma (373)
Machine learning (43)
Management (60)
Manufacturing (784)
MASH (163)
Medical device (13871)
Medtech (13923)
Mergers & acquisitions (20031)
Metabolic disorders (1256)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (313)
Neuropsychiatric disorders (87)
Neuroscience (2890)
Neurotech (1)
NextGen: Class of 2026 (6583)
Non-profit (4546)
Now hiring (65)
Obesity (589)
Opinion (260)
Ovarian cancer (165)
Pain (196)
Pancreatic cancer (222)
Parkinson's disease (282)
Partnered (33)
Patents (488)
Patient recruitment (476)
Peanut (55)
People (59133)
Pharmaceutical (65)
Pharmacy benefit managers (29)
Phase 1 (21745)
Phase 2 (30649)
Phase 3 (22824)
Pipeline (5109)
Policy (278)
Postmarket research (2567)
Preclinical (9244)
Press Release (66)
Prostate cancer (238)
Psychedelics (47)
Radiopharmaceuticals (279)
Rare diseases (818)
Real estate (5981)
Recruiting (69)
Regulatory (24528)
Reports (51)
Research institute (2433)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (147)
Series A (242)
Series B (188)
Service/supplier (11)
Sickle cell disease (99)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3648)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (84)
The Weekly (53)
Vaccines (987)
Venture capital (86)
Weight loss (379)
Women's health (87)
Worklife (18)
Date
Last 7 days (597)
Last 30 days (2018)
Last 365 days (30087)
2026 (2846)
2025 (30551)
2024 (35547)
2023 (40444)
2022 (51530)
2021 (56082)
2020 (54417)
2019 (46880)
2018 (35253)
2017 (32384)
2016 (31752)
2015 (37800)
2014 (31496)
2013 (26539)
2012 (28745)
2011 (29412)
2010 (27444)
Location
Africa (744)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39525)
Australia (6456)
California (11274)
Canada (3259)
China (1098)
Colorado (477)
Connecticut (477)
Delaware (332)
Europe (85649)
Florida (1672)
Georgia (359)
Hawaii (3)
Idaho (61)
Illinois (854)
India (62)
Indiana (514)
Iowa (22)
Japan (421)
Kansas (126)
Kentucky (39)
Louisiana (27)
Maine (72)
Maryland (1385)
Massachusetts (8098)
Michigan (321)
Minnesota (631)
Mississippi (5)
Missouri (134)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2972)
New Mexico (29)
New York (2972)
North Carolina (1443)
North Dakota (8)
Northern California (5486)
Ohio (333)
Oklahoma (22)
Oregon (41)
Pennsylvania (2262)
Puerto Rico (23)
Rhode Island (47)
South America (1117)
South Carolina (66)
South Dakota (1)
Southern California (4385)
Tennessee (174)
Texas (1737)
United States (39943)
Utah (337)
Vermont (1)
Virginia (263)
Washington D.C. (81)
Washington State (936)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
725,852 Results for "precision ibd inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Inflammatory bowel disease
Boehringer Commits up to $1.26B in IBD Pact With China’s Simcere
The cornerstone of the deal is SIM0709, which Simcere designed to target both TL1A and IL-23, crucial players in facilitating inflammation. Boehringer Ingelheim will advance the asset for inflammatory bowel diseases.
January 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board
January 29, 2026
·
7 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
January 7, 2026
·
4 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
January 7, 2026
·
4 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 5, 2026
·
1 min read
Press Releases
C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub
October 16, 2025
·
3 min read
Press Releases
Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5
November 21, 2025
·
5 min read
Inflammatory bowel disease
Roche Makes Preclinical IBD Play in $420M+ OMass Pact
The OMass partnership will boost Roche’s strategy in inflammatory bowel diseases, currently led by afimkibart, an anti-TL1A therapy the pharma obtained from its $7.1 billion acquisition of Telavant in 2023.
September 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)
November 13, 2025
·
2 min read
Press Releases
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
December 30, 2025
·
4 min read
1 of 72,586
Next
